Furthermore, there is increasing evidence of the role of FAP in additional fibroproliferative conditions such as idiopathic pulmonary fibrosis, hepatic fibrosis, rheumatoid arthritis and myocardial infarction (4–7). This evidence concerns the gene FAP and pulmonary fibrosis.